Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...
Medically reviewed by Lindsay Cook, PharmD Key Takeaways MS medications can help slow the disease and manage symptoms.
Dry needling has emerged as a minimally invasive intervention utilised in neurorehabilitation to manage spasticity, particularly following stroke. This technique involves the insertion of fine needles ...